PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.220
+0.010 (0.83%)
At close: Jan 28, 2026, 4:00 PM EST
1.236
+0.016 (1.32%)
After-hours: Jan 28, 2026, 4:59 PM EST
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $64.92 million as of January 28, 2026. Its market cap has decreased by -14.07% in one year.
Market Cap
64.92M
Enterprise Value
-63.93M
1-Year Change
-14.07%
Ranking
Category
Stock Price
$1.22
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $64.92M, a decrease of -95.98%. That is a compound annual growth rate of -45.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 64.39M | -3.20% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 64.97M |
| TScan Therapeutics | 64.13M |
| InflaRx | 63.07M |
| NRx Pharmaceuticals | 62.76M |
| Metagenomi Therapeutics | 62.70M |
| Acrivon Therapeutics | 61.22M |
| MiNK Therapeutics | 59.99M |
| Alterity Therapeutics | 59.77M |